- Research Article
- Open Access
Piscine orthoreovirus infection in Atlantic salmon (Salmo salar) protects against subsequent challenge with infectious hematopoietic necrosis virus (IHNV)
© The Author(s) 2018
- Received: 22 December 2017
- Accepted: 26 February 2018
- Published: 13 March 2018
Infectious hematopoietic necrosis virus (IHNV) is endemic in farmed rainbow trout in continental Europe and in various salmonid fish species at the Pacific coast of North America. IHN has never occurred in European Atlantic salmon (Salmo salar) farms, but is considered as a major threat for the European salmon industry. Another virus, Piscine orthoreovirus (PRV), is widespread in the sea phase of Atlantic salmon, and is identified as the causative agent of heart and skeletal muscle inflammation. The aim of this study was to investigate the interactions between a primary PRV infection and a secondary IHNV infection under experimental conditions. A PRV cohabitation challenge was performed with Atlantic salmon. At peak of PRV viremia the fish were challenged by immersion with an IHNV genogroup E isolate. Clinical signs and morbidity were monitored. Target organs were sampled at selected time points to assess viral loads of both pathogens. Antiviral immune response and presence of histopathological findings were also investigated. Whereas the PRV-negative/IHNV positive group suffered significant decrease in survival caused by IHNV, the PRV infected groups did not suffer any morbidity and showed negligible levels of IHNV infection. Antiviral response genes were induced, as measured in spleen samples, from PRV infected fish prior to IHNV challenge. In conclusion, PRV-infection protects Atlantic salmon against IHNV infection and morbidity, most likely by inducing a protective innate antiviral response.
Viral pathogens constantly challenge finfish aquaculture. In net pens, farmed stocks can be exposed to pathogens through water at any given time. Therefore, knowledge about effects of co-infections and pathogen interactions is important for development and implementation of effective disease control strategies.
Infectious hematopoietic necrosis virus (IHNV) is a member of the Rhabdoviridae family, genus Novirhabdovirus, which are bullet shaped viruses with non-segmented, negative single stranded RNA genome. IHNV is the causative agent of infectious hematopoietic necrosis (IHN), a widespread disease mainly found in salmonid fish species in western North-America, continental Europe and Asia ; IHN belongs to the list of notifiable listed disease according to current legislation . Clinically affected fish externally show the skin darkening, exophthalmia and pale gills. Common necropsy findings are pale internal organs with petechial hemorrhages, and intestines often filled with mucus-like fluid .
The presence of IHNV in Europe was first confirmed in 1987, with at least two different introductions in Italy and France, with viruses originating from the M genogroup. Since then, IHNV has spread in different European countries, evolving separately and constituting the E genogroup which is the youngest within IHNV genogroups . IHNV is currently endemic in continental Europe and can be associated with significant losses in freshwater farmed rainbow trout (Onchorynchus mykiss), while countries producing Atlantic salmon in northern Europe are declared officially free from the virus according to European legislation . The virus is widespread in western North-America, including seawater areas with Atlantic salmon farming, where a DNA vaccine is used to control the disease . In the seawater phase both Pacific salmonid species and Atlantic salmon are susceptible to infection .
Piscine orthoreovirus (PRV) is ubiquitous in farmed salmon in Norway during the sea water phase, and has emerged in recent years as a relevant threat for Atlantic salmon aquaculture being the etiological agent of heart and skeletal muscle inflammation (HSMI) [8–12]. PRV is a non-enveloped virus with a segmented double-stranded RNA genome enclosed in a capsid with two concentric protein layers , currently PRV cannot be cultivated in vitro un cell culture monolayers. The gross pathological findings of HSMI point towards circulatory failure, and characteristic histopathological findings are epi-, endo- and myocarditis, myocardial necrosis, red skeletal myositis and necrosis . PRV infection in Atlantic salmon induces a strong innate antiviral immune response in its major target cell, the erythrocyte , and thus this response can be measured in any vascularized organ, and has been described in various organs such as spleen, head kidney and heart tissue [10, 16].
In this study, we show that a preceding PRV infection in Atlantic salmon interferes with a subsequent challenge with genogroup E IHNV, fully protecting the fish from infection and IHN disease development. The experiment also demonstrated the susceptibility of Atlantic salmon for IHNV, genogroup E.
Experimental design and fish sampling
The experiments were carried out in the facilities at DTU-VET (Frederiksberg, Denmark) in accordance with the recommendations in the current animal welfare regulations under the license 2013-15-2934-00976. The protocols were approved by the Danish Animal Research Authority.
The fish were monitored on a daily basis regarding state of health and environment.
Atlantic salmon juveniles (mean weight of 5 g) were imported from a commercial farm certified free from listed diseases according to EU legislation (CD 2006/88) also including infectious pancreatic necrosis virus (IPNV) and bacterial kidney disease (BKD). The fish were brought into the quarantine facility, using recirculated tap water disinfected by UV, temperature = 12 °C ± 1, and kept there for 75 days. Before starting the trial, the experimental fish were screened for IHNV, IPNV and viral haemorrhagic septicemia virus (VHSV) inoculating organ homogenate on cell culture according to a Council implementing decision 2015-1554 . Furthermore, fish were screened by qPCR for salmonid alphaviruses (SAV), according to OIE Manual of Diagnostic Tests for Aquatic Animals  and PRV . Bacteriological analysis was performed according to standard diagnostic procedures, by streaking kidney tissue onto blood agar (BA) and Tryptone Yeast Extract Salts (TYES), followed by incubation for 1 week at 20 and 15 °C, respectively. All tests for all pathogens were negative prior to the infection trial.
Prevalence of hearts with lesions consistent with HSMI
For the pathogenesis study the 150 L tanks of each group PRV−/IHNV+, PRV+/IHNV+, PRV−/IHNV−, and PRV+/IHNV− were repeatedly sampled to monitor virus kinetics and antiviral responses. To study pathogenicity, duplicate tanks of the groups PRV−/IHNV+ and PRV+/IHNV+ (20 fish per group) were transferred to small bowls (8 L) upon IHNV challenge and monitored for clinical signs, disease development and mortality for 45 days.
Prior to organ sampling, fish were anesthetized with benzocaine chloride (800 mg/1 L water) and euthanized by cervical transection. During the first 4 weeks post PRV challenge, blood, spleen and heart samples were taken weekly from two shedders and two cohabitants from PRV exposed and non-exposed tanks (tanks 3–6). Weight and length of each animal were recorded.
In the second part of the trial, i.e. after the IHNV challenge, three shedders and three cohabitants from each of the 150 L tanks (2, 4, 5 and 6) were sampled more frequently, i.e. at 2, 5, 12, 19, 26 and 33 days post IHNV infection. During this latter phase, head kidney was added to the sampling sets. Spleen and head kidney were stored in RNALater® (ThermoFisher Scientific Inc, USA). Hearts were divided along the midsagittal line, storing one part in RNALater® (ThermoFisher Scientific Inc) and the other in 10% buffered formalin for histopathological assessment. Blood was sampled from the caudal vein on heparinized tubes (BD Biosciences, USA) and aliquoted for both hematocrit and hemoglobin evaluation in a Hematology Analyzer (Vet ABC, Scil, USA) and to prepare blood smears for immunofluorescence staining. The experiment was terminated 45 days after IHNV challenge (corresponding to 73 days after PRV challenge).
PRV cohabitation challenge
The PRV inoculum used for infection originated from a field outbreak of HSMI in Norway in 2012 that had subsequently been passaged in three PRV challenge experiments at VESO Vikan (Oslo, Norway) in which HSMI was reproduced . Briefly, heparinized blood was collected from three PRV infected fish 7 weeks post cohabitation challenge. Blood was centrifuged to remove plasma and the remaining blood pellet was pooled and diluted 1:3 in Leibovitz’s L15 medium (Life Technologies, USA) supplemented with gentamicin at 50 μg/mL (Gibco, USA) and Fungizone at 0.25 g/mL (Gibco). The pellet kept on ice was sonicated ten times for 10 s each at 20 kHz and centrifuged at 2000 × g. The resulting supernatant was shown to contain high loads of PRV as determined by RT-qPCR (Ct value of 18.6/5 µL inoculum).
Fish dedicated to be shedders (n = 40 per tank) were injected intra-peritoneal (i.p.) with 0.1 mL of challenge material under anesthesia with benzocaine (80 mg/L) and marked by clipping of the adipose fin. Fifty-five naïve unmarked cohabitants were added to each tank, resulting in a shedder ratio of 42%.
In PRV negative tanks shedders were mock injected with 0.1 mL of naïve rainbow trout blood (tested negative for PRV by RT-qPCR) prepared like the PRV infected inoculum.
IHNV immersion challenge
Four weeks post PRV infection, upon the peak of PRV viremia (median PRV Ct value obtained in cohabitants = 19.8), IHNV challenge was performed in tanks 1, 2, 3 and 4. Before IHNV challenge 40 fish from each of the duplicate tanks 1 and 3 (PRV−/IHNV+ and PRV+/IHNV+) were transferred to 8 L bowls (20 fish in each, i.e. 10 PRV shedders and 10 PRV cohabitants). In order to maintain the same biomass during the challenge time (3 h) fish from tanks 2 and 4 were transferred into 30 L tanks for the IHNV challenge, and then transferred back in the original 150 L tanks. Remaining fish from tank 1 and 3 were excluded from the trial.
For IHNV challenge, the German isolate DF04/99, proven to be highly virulent to rainbow trout  was propagated in EPC (Epithelioma Papulosum Cyprini, ATCC® C RL-2872™) cell monolayers at 15 °C, frozen once and titrated (Kärber method)  in EPC cells. IHNV immersion challenge dose was estimated as 106 TCID50/mL, whereas fish from tank 5 and 6 where mock challenged with sterile L15 media. Fish were challenged for a period of 3 h.
Fish separated into the bowls for the pathogenicity study were monitored daily for clinical signs of disease. Individual fish displaying clinical signs of IHN (apathy, skin darkening, exophthalmos and abnormal behavior) were euthanized by an overdose of benzocaine chloride (500 mg/L). Head kidney, heart and spleen from clinically affected fish were sampled and pooled in MEM (Minimum Essential Medium, Sigma Aldrich, USA) following the criteria of one pool per bowl per day, for later confirmation of IHNV infection by RT-qPCR.
RT-qPCR for assessing viral loads
RT-qPCR was performed on RNA purified from spleen. Total RNA was purified using Qiagen RNeasy mini kit (QIAGEN, Germany) and the final RNA eluted in 30 µL of RNAse free water. RNAse free water was used as a negative control and positive blood sample was used as a positive control.
RT-qPCR was carried out using QuantiTect Probe RT-PCR Kit (QIAGEN), according to the manufacturer’s instructions. Briefly, for each sample, 5 µL of purified RNA was mixed with 4.75 µL of RNAse free water; 12.5 µL of 2X QIAGEN Quantitect Probe Mix; 1 µL of each primer at 10 µM; 0.5 µL of the probe and 0.25 µL of QIAGEN Quantitect Enzyme Mix. RNAse free water was used as a negative control. Primers, probes and working conditions for RT-qPCR for PRV and IHNV are described elsewhere [9, 22].
RT-qPCR was performed on Stratagene Mx3005P and Mx3000P qPCR-systems, with MxPro (v. 4.10) software used for RT-qPCR data analysis. According to internal Standard Operating Procedure cut-off value was set as 35 Ct, samples with higher Ct values were considered doubtful, given sigmoidal shape of related amplification plot; otherwise they were considered negative.
From day 2 after IHNV challenge heart sections from 122 fish were assessed by histopathological examination.
Tissue samples stored in 10% neutral buffered formalin were embedded in paraffin and routinely processed into sections of 3–4 µm thickness, stained with haematoxylin and eosin (H&E) and examined by light microscopy. Histopathological changes in the heart consistent with HSMI were scored as none or very sparse (0–0.5), mild focal (1), mild to moderate multifocal (1.5), moderate diffuse (2) and severe diffuse findings (2.5), modified after guidelines previously provided  (Figure 5).
Immunofluorescence antibody test (IFAT) for PRV
An immunofluorescence antibody test (IFAT) was performed on blood smears using a polyclonal antibody raised in rabbits against the putative PRV outer capsid protein ơ1 (anti-ơ1)  as described previously . The panel of samples included five selected specimens from PRV-infected blood collected at the peak of viremia, chosen based on low Ct levels. Uninfected blood samples, i.e. negative by RT-qPCR, were used as negative controls.
Immune gene response analysis
A selection of spleen samples from PRV cohabitants (n = 3–6 per sampling point) were homogenized individually in 500 µL QIAzol Lysis Reagent (QIAGEN) with 5 mm steel beads in a TissueLyser II (QIAGEN). Total RNA was isolated by chloroform extraction and ethanol precipitation and loaded onto an RNeasy mini spin column (QIAGEN). Further purification was performed according to the RNeasy kit instructions, and the final RNA concentration was measured using a NanoDropTM 2000 spectrophotometer. Total RNA (500 ng) from each sample was used for cDNA synthesis using the QuantiTect Reverse Transcription kit (QIAGEN) with a genomic DNA elimination step. For RT-qPCR analysis, cDNA corresponding to 10 ng RNA was analysed in triplets for 40 cycles of 94 °C for 15 s and 60 °C for 30 s. Levels of elongation factor 1 α (EF1α), Mx-1, interferon (IFN)a and IFNc mRNA were assessed using 500 nM forward and reverse primers , and the Maxima SYBR Green/ROX qPCR Master Mix (Fisher Scientific). The specificity of the SYBR Green assay was confirmed by melting point analysis. An eight point concentration standard curve (two-fold dilutions) made from a representable mix of samples was run on each plate and used to calculate relative gene expression differences. Levels of EF1α mRNA were used for normalization .
To compare the differential survival rate, the Kaplan–Meier estimator was used. Log-rank (Mantel-Cox) test was applied to verify the equality of survivor functions across groups. To investigate the difference measured in haematocrit and haemoglobin levels between the different experimental groups One way ANOVA followed by Kruskall–Wallis test was performed. All statistical analyses were performed using GraphPad Prism version 6.00 for Windows, GraphPad Software, La Jolla, California, USA).
Protective effect of PRV infection against subsequent IHNV challenge
Time course detection of PRV and IHNV
IHNV infection kinetics developed as an acute infection characterized by high viral loads in spleen followed by substantial decrease in the PRV− IHNV+ group. IHNV RNA was detected in spleen as early as 5 days post IHNV challenge (1 of 3 fish tested IHNV positive, Ct 24.7); and at day 9, 2 of 3 fish tested IHNV positive (Ct 25.8 and 21.1). Thereafter, the Ct values and the number of positive fish decreased and at the last sampling at day 33, IHNV RNA was detected at negligible level in only 1 sample (Ct 39.7).
In the co-challenged group PRV+ IHNV+, IHNV RNA was detected at negligible levels in only 1 sample throughout the whole experiment, at day 5 post IHNV challenge (Ct 38.5) (Figure 3B).
The results obtained by RT-qPCR were corroborated corroborated by immunofluorescent detection of PRV outer capsid protein σ1 in cytoplasmic and perinuclear inclusions of blood cells from (Figure 3C).
Modulation of IFNa, IFNc and Mx expression in PRV infected and IHNV co-challenged fish
HSMI prevalence and severity
Variations in hematocrit and hemoglobin during infection
Salmonid aquaculture worldwide largely relies on production in net pens. This production mode introduces a risk of potential transfer of pathogens between wild and farmed stocks. Wild stocks may harbor several infective agents, and farmed fish may act as amplifiers of pathogens posing a risk to the wild stocks in the eco-system of the farming area. Therefore, knowledge about host–pathogen interactions and pathogen–pathogen interplay is critical for both ecological and economic reasons, and thus for the development of a sustainable salmon farming industry.
This study brings interesting elements to consider for an exhaustive risk assessment analysis of the spread of IHNV from continental Europe to Atlantic salmon aquaculture industry in northern Europe. The recent report from November 2017 (OIE notification) of IHN outbreaks in rainbow trout in Finland highlights the importance of such an assessment.
The specific aim was to investigate the effect of PRV infection, which is very common in Atlantic salmon in Northern Europe, to a subsequent exposure to IHNV, belonging to the European genogroup E.
The results showed significant IHNV resistance in PRV infected compared to non-PRV infected Atlantic salmon. The PRV infected, IHNV challenged fish showed no mortality and only negligible levels of IHNV RNA were detected. On the contrary, Atlantic salmon not exposed to PRV showed clinical signs of IHN such as skin darkening, exophthalmia and lethargy, leading to reduced survival rate of 93% in 150 L tanks and 50% in 8 L bowls. The difference between the survival rates in the two settings can be related to the higher biomass and density in this experimental unit (13 kg/m3 in tanks and 70 kg/m3 in bowls), as it has been previously reported that host density is a key factor for the incidence and severity of IHNV infections .
Our findings are in agreement with the results obtained by Lund et al.  where it was demonstrated that a preceding PRV infection mediated protection against a subsequent SAV challenge, shown by reduction in SAV RNA levels and reduced severity of the related pathological lesions. On the other hand, our findings diverge considerably from those described by Polinski et al. , where a PRV challenge conducted in Sockeye salmon (Oncorhynchus nerka) using a viral strain from British Columbia showed no effect on host immune responses or protection against a subsequent IHNV infection. However, some significant differences in the two experimental settings may provide explanations for the differences observed. Firstly, different species were infected in the trials; S. salar (this study) and O. nerka in the Polinsky study, and different species often show different responses to the same pathogen [28, 29]. One example of this is that the PRV strain found in rainbow trout in Europe cause an HSMI like disease in this species, but only affects Atlantic salmon to a minor degree and with little induction of antiviral responses . Secondly, the PRV challenges were performed differently, since i.p. injection of virus was performed in the Sockeye salmon challenge, while a cohabitation trial, which better mimics natural infection, was used in our Atlantic salmon challenge. It is also worth reporting that the peak viral load was slightly higher in the cohabitant fish than in the i.p. injected shedders in our experiment. Thirdly, the Sockeye salmon were subjected to IHNV immersion challenge 2 weeks after PRV injection, while in our study PRV infection were allowed to develop for 4 weeks, reaching peak viral loads prior to IHNV immersion challenge. Notably, according to Dahle et al. , the peak in PRV viral load is correlated with the peak induction of IFN-regulated antiviral responses in Atlantic salmon blood cells. Finally, different viral strains were included in the different studies. We used a Norwegian PRV strain shown to cause HSMI, whereas the ability of the British Columbia PRV strain to cause disease is not clearly defined yet [8, 30]. In regard to IHNV, a European isolate was used in this study as part of a targeted risk assessment, whereas the American isolate BC93-057, genogroup U was used in the study of Polinski .
The difference between the IHNV susceptibility of the PRV+/IHNV+ group and the PRV−/IHNV+ group was striking. The PRV−/IHNV+ showed 50% survival while in the co-challenged group all fish survived. This suggests that PRV infection is highly protective against the IHNV E genogroup, which is well described in terms of phenotypic  and genetic profile . This finding was corroborated by RT-qPCR analysis assessing the presence of PRV and IHNV genome in spleen samples throughout the experiment. IHNV was detected in most of the non-PRV infected fish, depicting the kinetics of an acute infection, while IHNV was detected at a very low level (Ct 38.5) in only one of the PRV-infected fish.
In agreement with previous studies performed in Atlantic salmon [15, 32] PRV induced an increase in the gene expression of IFN (IFNa and IFNc) and Mx. In general, this immunological pathway is pivotal in protection against viral infections in vertebrates, including Atlantic salmon [33, 34]. In our experiment, PRV induced increased IFNa and Mx expression in spleen, the organ where PRV-infected erythrocytes are likely to accumulate.
In rainbow trout, effective protection from virulent novirhabdoviruses is shown to be elicited through the IFN response, as indicated by the protective effect of a preceding infection with virus such as IPNV, which, like PRV, is a non-enveloped dsRNA virus [35, 36]. IFN regulated genes are also induced by intramuscular administration of DNA vaccines against IHNV . DNA vaccination against IHNV has proven to give effective protection already as early as 4 days after injection against homologous  and heterologous novirhabdoviruses , highlighting the importance of innate immune responses in protection against novirhabdovirus.
In order to assess the pathological effect of viral challenge, heart, which is an important target organ for the two pathogens, was analysed by histology. The majority of the hearts from fish in both PRV+/IHNV− and PRV+/IHNV+ groups developed histopathological findings consistent with HSMI. The lesions varied from mild to severe, and there was no difference in the prevalence of heart lesions between the two groups. However, an interesting trend was observed when scoring the severity of the lesions in the two groups, as six out of seven hearts with the most severe findings were seen in the hearts of PRV+/IHNV− cohabitants group, suggesting that exposure to IHNV may possibly modify the host inflammatory response to the PRV infection. This observation however has to be further investigated.
Interestingly, both PRV and IHNV infection significantly affected haematocrit and haemoglobin levels. PRV infected fish suffered from significant anaemia (as measured by both parameters) compared to negative control groups at the time of IHNV exposure in the trial, which corresponds to the peak in PRV load. Similarly, in the PRV−/IHNV+ group, the haemoglobin parameter was significantly reduced compared to the control group at the end of the experiment, but with largest reduction at day 9 post IHNV exposure, i.e. correlating with the peak of IHNV infection.
In conclusion, the results show that Atlantic salmon is susceptible to the IHNV genogroup E, which is present in continental Europe, and that a preceding PRV infection protects against subsequent IHNV challenge when conducted at the peak of PRV viremia. The protection observed in this study is likely to be related to the PRV-induced innate antiviral responses, such as IFN and IFN-stimulated genes. Further studies are needed to unravel the mechanism behind the observed protection, the duration of protection, and its possible specificity towards other viral pathogens.
The authors declare that they have no competing interests.
NJO, NV and ER launched the project idea. NJO, ALF, NV and ER participated in the overall design and coordination of the study, interpretation of data and drafting the manuscript. ALF and NV conducted the trial, performed sampling and tested samples for viral kinetics. MKD performed gene expression analysis. ABO and TMI performed histopathological examination of samples collected. ØW, TMI, MKD and ABO participated in the coordination of the study, revised the manuscript and provided significant contribution to figures and text. All authors read and approved the final manuscript.
This study was co-funded by the European Reference Laboratory for Fish diseases at DTU National Veterinary Institute and FAPESP (Sao Paulo Research Foundation) Research internship abroad (2015/04027-6). Immune gene analysis was financed by the Norwegian Research Council (NRC) Grant # 237315/E40 (ViVaFish). Histology was financed by the Norwegian Veterinary Institute. A special thanks to the fish diseases group at DTU-VET and the teams at NVI in Oslo and Bergen for technical support during the study.
Ethics approval and consent to participate
The experiments were carried out in the facilities at DTU-VET (Frederiksberg, Denmark) in accordance with the recommendations in the current animal welfare regulations under the license 2013-15-2934-00976. The protocols were approved by the Danish Animal Research Authority.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Dixon P, Paley R, Alegria-Moran R, Oidtmann B (2016) Epidemiological characteristics of infectious hematopoietic necrosis virus (IHNV): a review. Vet Res 47:63View ArticlePubMedPubMed CentralGoogle Scholar
- The European Commission (2006) Council Directive 2006/88/EC on animal health requirements for aquaculture animals products thereof, and on the prevention and control of certain diseases in aquaculture. Off J Eur Union 328:14–56Google Scholar
- OIE (2017) Manual of diagnostic tests for aquatic animals. OIE, ParisGoogle Scholar
- Bellec L, Louboutin L, Cabon J, Castric J, Cozien J, Thiéry R, Thierry M (2017) Molecular evolution and phylogeography of infectious hematopoietic necrosis virus with a focus on its presence in France over the last 30 years. J Gen Virol 98:2438–2446View ArticleGoogle Scholar
- Enzmann PJ, Kurath G, Fichtner D, Bergmann SM (2005) Infectious hematopoietic necrosis virus: monophyletic origin of European isolates from North American genogroup M. Dis Aquat Organ 66:187–195View ArticlePubMedGoogle Scholar
- Long A, Richard J, Hawley L, LaPatra SE, Garver KA (2017) Transmission potential of infectious hematopoietic necrosis virus in APEX-IHN®-vaccinated Atlantic salmon. Dis Aquat Organ 122:213–221View ArticlePubMedGoogle Scholar
- Kurath G, Winton JR, Dale OB, Purcell MK, Falk K, Busch RA (2016) Atlantic salmon, Salmo salar L. are broadly susceptible to isolates representing the North American genogroups of infectious hematopoietic necrosis virus. J Fish Dis 39:55–67View ArticlePubMedGoogle Scholar
- Wessel Ø, Braaen S, Alarcon M, Haatveit H, Roos N, Markussen T, Tengs T, Dahle MK, Rimstad E (2017) Infection with purified Piscine orthoreovirus demonstrates a causal relationship with heart and skeletal muscle inflammation in Atlantic salmon. PLoS One 12:e0183781View ArticlePubMedPubMed CentralGoogle Scholar
- Palacios G, Lovoll M, Tengs T, Hornig M, Hutchison S, Hul J, Kogtorp RT, Savjl N, Bussetti AV, Solovyov A, Kristoffersen AB, Celone C, Street C, Trifonov V, Hirschberg DL, Rabadan R, Egholm M, Rimstad E, Lipkin WI (2010) Heart and skeletal muscle inflammation of farmed salmon is associated with infection with a novel reovirus. PLoS One 5:e11487View ArticlePubMedPubMed CentralGoogle Scholar
- Haatveit HM, Wessel Ø, Markussen T, Lund M, Thiede B, Nyman IB, Braen S, Dahle MK, Rimstad E (2017) Viral protein kinetics of Piscine orthoreovirus infection in Atlantic salmon blood cells. Viruses 9:E49View ArticlePubMedGoogle Scholar
- Tengs T, Rimstad E (2017) Emerging pathogens in the fish farming industry and sequencing-based pathogen discovery. Dev Comp Immunol 75:109–119View ArticlePubMedGoogle Scholar
- Løvoll M, Austbø L, Jørgensen JB, Rimstad E, Frost P (2011) Transcription of reference genes used for quantitative RT-PCR in Atlantic salmon is affected by viral infection. Vet Res 42:8View ArticlePubMedPubMed CentralGoogle Scholar
- Markussen T, Dahle MK, Tengs T, Løvoll M, Finstad ØW, Wiik-Nielsen CR, Grove S, Lauksund Robertsen B, Rimstad E (2013) Sequence analysis of the genome of Piscine orthoreovirus (PRV) associated with heart and skeletal muscle inflammation (HSMI) in Atlantic salmon (Salmo salar). PLoS One 8:e70075View ArticlePubMedPubMed CentralGoogle Scholar
- Kongtorp RT, Kjerstad A, Taksdal T, Guttvik A, Falk K (2004) Heart and skeletal muscle inflammation in Atlantic salmon, Salmo salar L: a new infectious disease. J Fish Dis 27:351–358View ArticlePubMedGoogle Scholar
- Dahle MK, Wessel Ø, Timmerhaus G, Nymam IB, Jørgensen SM, Rimstad E, Krasnov A (2015) Transcriptome analyses of Atlantic salmon (Salmo salar L.) erythrocytes infected with piscine orthoreovirus (PRV). Fish Shellfish Immunol 45:780–790View ArticlePubMedGoogle Scholar
- Johansen LH, Dahle MK, Øystein Wessel, Timmerhaus G, Løvoll M, Røsæg M, Jørgensen SM, Rimstad E, Krasnov A (2016) Differences in gene expression in Atlantic salmon parr and smolt after challenge with Piscine orthoreovirus (PRV). Mol Immunol 73:138–150View ArticlePubMedGoogle Scholar
- The European Commission (2015) Decision (EU) 2015/1554. Off J Eur Union 2001:20–30. http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2015.247.01.0001.01.ENG
- OIE (2017) Infection with salmonid alphavirus. OIE Aquat Anim Dis Cards, Manual of Diagnostic Tests for Aquatic Animals, Chapter 2.3.6, pp 4–6. http://www.oie.int/fileadmin/Home/eng/Health_standards/aahm/current/chapitre_salmonid_alphavirus.pdf
- Lund M, Røsæg MV, Krasnov A, Timmerhaus G, Nyman IB, Aspehaug V, Rimstad E, Dahle MK (2016) Experimental Piscine orthoreovirus infection mediates protection against pancreas disease in Atlantic salmon (Salmo salar). Vet Res 47:107View ArticlePubMedPubMed CentralGoogle Scholar
- Bergmann SM, Fichtner D, Skall HF, Scholtfeldt HJ, Olesen NJ (2003) Age- and weight-dependent susceptibility of rainbow trout Oncorhynchus mykiss to isolates of infectious haematopoietic necrosis virus (IHNV) of varying virulence. Dis Aquat Organ 55:205–210View ArticlePubMedGoogle Scholar
- Kärber G (1931) Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn-Schmiedebergs Arch für Exp Pathol und Pharmakologie 162:480–483 (in Dutch)Google Scholar
- Purcell MK, Thompson RL, Garver KA, Hawley LM, Batts WN, Sprague L, Sampson L, Sampson C, Winton JR (2013) Universal reverse-transcriptase real-time PCR for infectious hematopoietic necrosis virus (IHNV). Dis Aquat Organ 106:103–115View ArticlePubMedGoogle Scholar
- Finstad ØW, Dahle MK, Lindholm TH, Nyman IB, Løvoll M, Wallace C, Olsen CM, Storset AK, Rimstad E (2014) Piscine orthoreovirus (PRV) infects Atlantic salmon erythrocytes. Vet Res 45:35View ArticlePubMedPubMed CentralGoogle Scholar
- Hauge H, Vendramin N, Taksdal T, Olsen AB, Wessel Ø, Mikkelsen SS, Alencar ALF, Olesen NJ, Dahle MK (2017) Infection experiments with novel Piscine orthoreovirus from rainbow trout (Oncorhynchus mykiss) in salmonids. PLoS One 12:e0180293View ArticlePubMedPubMed CentralGoogle Scholar
- Grove S, Austbø L, Hodneland K, Frost P, Løvoll M, McLoughlin M, Thim HL, Braeen S, König M, Syed M, Jørgensen JB, Rimstad E (2013) Immune parameters correlating with reduced susceptibility to pancreas disease in experimentally challenged Atlantic salmon (Salmo salar). Fish Shellfish Immunol 34:789–798View ArticlePubMedGoogle Scholar
- Ogut H, Reno PW (2004) Effects of fish density on spread of infections hematopoietic necrosis virus (IHNV) in rainbow trout, Oncorhynchus mykiss. Isr J Aquac 56:128–133Google Scholar
- Polinski MP, Bradshaw JC, Inkpen SM, Richard J, Fritsvold C, Poppe TT, Rise ML, Garver KA, Johnson SC (2016) De novo assembly of Sockeye salmon kidney transcriptomes reveal a limited early response to piscine reovirus with or without infectious hematopoietic necrosis virus superinfection. BMC Genomics 17:848View ArticlePubMedPubMed CentralGoogle Scholar
- Fast MD, Sims DE, Burka JF, Mustafa A, Ross NW (2002) Skin morphology and humoral non-specific defence parameters of mucus and plasma in rainbow trout, coho and Atlantic salmon. Comp Biochem Physiol Part A Mol Integr Physiol 132:645–657View ArticleGoogle Scholar
- Chevassus B, Dorson M (1990) Genetics of resistance to disease in fishes. Aquaculture 85:83–107View ArticleGoogle Scholar
- Garver KA, Johnson SC, Polinski MP, Bradshaw JC, Marty GD, Snyman HN, Morrison DB, Richard J (2016) Piscine orthoreovirus from western North America is transmissible to Atlantic salmon and sockeye salmon but fails to cause heart and skeletal muscle inflammation. PLoS One 11:e0146229View ArticlePubMedPubMed CentralGoogle Scholar
- Johansson T, Einer-Jensen K, Batts W, Ahrens P, Björkblom C, Kurath G, Björklund H, Lorenzen N (2009) Genetic and serological typing of European infectious haematopoietic necrosis virus (IHNV) isolates. Dis Aquat Organ 86:213–221View ArticlePubMedGoogle Scholar
- Røsæg MV, Lund M, Nyman IB, Markussen T, Aspehaug V, Sindre H, Dahle MK, Rimstad E (2017) Immunological interactions between Piscine orthoreovirus and Salmonid alphavirus infections in Atlantic salmon. Fish Shellfish Immunol 64:308–319View ArticlePubMedGoogle Scholar
- Chang CJ, Sun B, Robertsen B (2015) Adjuvant activity of fish type I interferon shown in a virus DNA vaccination model. Vaccine 33:2442–2448View ArticlePubMedGoogle Scholar
- Chang CJ, Robertsen C, Sun B, Robertsen B (2014) Protection of Atlantic salmon against virus infection by intramuscular injection of IFNc expression plasmid. Vaccine 32:4695–4702View ArticlePubMedGoogle Scholar
- Hyoung JK, Oseko N, Nishizawa T, Yoshimizu M (2009) Protection of rainbow trout from infectious hematopoietic necrosis (IHN) by injection of infectious pancreatic necrosis virus (IPNV) or Poly(I:C). Dis Aquat Organ 83:105–113View ArticleGoogle Scholar
- Byrne N, Castric J, Lamour F, Cabon J, Quentel C (2008) Study of the viral interference between infectious pancreatic necrosis virus (IPNV) and infectious haematopoietic necrosis virus (IHNV) in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol 24:489–497View ArticlePubMedGoogle Scholar
- Purcell MK, Kurath G, Garver KA, Herwig RP, Winton JR (2004) Quantitative expression profiling of immune response genes in rainbow trout following infectious haematopoietic necrosis virus (IHNV) infection or DNA vaccination. Fish Shellfish Immunol 17:447–462View ArticlePubMedGoogle Scholar
- LaPatra SE, Corbeil S, Jones GR, Shewmaker WD, Kurath G (2000) The dose-dependent effect on protection and humoral response to a DNA vaccine against infectious hematopoietic necrosis (IHN) virus in subyearling rainbow trout. J Aquat Anim Health 12:181–188View ArticleGoogle Scholar
- Lorenzen N, Lorenzen E, Einer-Jensen K, LaPatra SE (2002) Immunity induced shortly after DNA vaccination of rainbow trout against rhabdoviruses protects against heterologous virus but not against bacterial pathogens. Dev Comp Immunol 26:173–179View ArticlePubMedGoogle Scholar